Abbott Laboratories (ABT) said Tuesday that it has agreed to integrate data from its Libre continuous glucose monitoring systems into Epic's electronic health record systems in the US under a collaboration agreement.
Abbott said the collaboration will streamline access to CGM data for healthcare organizations.
Price: 130.76, Change: +1.23, Percent Change: +0.95
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。